The company said its diagnostics business crossed an annualised revenue run rate of more than Rs 600 crore during the year, growing over 40 per cent year-on-year while sustaining double-digit Ebitda margins.

The company said its diagnostics business crossed an annualised revenue run rate of more than Rs 600 crore during the year, growing over 40 per cent year-on-year while sustaining…

Tata 1mg turned EBITDA positive across its core businesses in FY26 as diagnostics, ePharmacy and AI-led healthcare services expanded rapidly.